Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Vaccination site pain
Clinical narrative: body aches; Headache; mild chills; extremely pain at injection site; fatigue; This is a spontaneous report received from a Consumer or other non HCP.  A 27-year-old female patient (not pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 10Oct2024 at 16:30 as dose 1, single (Batch/Lot number: unknown) at the age of 27 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "hyperthyroidism" (unspecified if ongoing). Concomitant medication(s) included: INFLUENZA VACCINE taken for immunisation, on 18Sep2024 as dose number unknown, single. The patient also took other concomitant therapy. Past drug history included: Amoxicillin, reaction(s): "Allergy". Vaccination history included: BNT162b2 (dose 1, single, Intramuscular at 10:15, lot: EL 3247, anatomical location: arm left), administration date: 28Jan2021, when the patient was 23-year-old, for Covid-19 immunization, reaction(s): "Vaccination site movement impairment", "Vaccination site pain"; BNT162b2 (dose 1, single, Intramuscular at 10:15, lot: EL 3247, anatomical location: arm left), administration date: 18Feb2021, when the patient was 23-year-old, for Covid-19 immunization, reaction(s): "Nausea", "Myalgia", "Chills", "Fatigue", "Pyrexia", "Headache"; BNT162b2 (dose 3 (booster), single, Intramuscular at 10:30, lot: FH8027, anatomical location: arm left), administration date: 20Dec2021, when the patient was 24-year-old, for Covid-19 immunization, reaction(s): "Vaccination site rash", "Axillary pain", "Vaccination site pain", "Dyskinesia", "Chills", "Myalgia", "Pyrexia", "Headache"; BNT162b2, BNT162b2 omi ba.4-5 (dose 4 (booster), single, Intramuscular at 17:45, lot: GJ2524, anatomical location: arm left), administration date: 09Dec2022, when the patient was 25-year-old, for Covid-19 immunization, reaction(s): "Pyrexia", "Myalgia", "Chills", "Headache", "Vaccination site pain", "Pain in extremity"; comirnaty (2023-2024 formula) (dose 5 (booster), single, Intramuscular at 13:15, anatomical location: arm left), administration date: 18Oct2023, when the patient was 26-year-old, for Covid-19 immunization, reaction(s): "Nausea", "Vaccination site pain", "Pain in extremity", "Chills", "Pain", "Headache". The following information was reported: HEADACHE (non-serious) with onset 11Oct2024 at 07:00, outcome "not recovered"; PAIN (non-serious) with onset 11Oct2024 at 07:00, outcome "not recovered", described as "body aches"; VACCINATION SITE PAIN (non-serious) with onset 11Oct2024 at 07:00, outcome "not recovered", described as "extremely pain at injection site"; FATIGUE (non-serious) with onset 11Oct2024 at 07:00, outcome "not recovered"; CHILLS (non-serious) with onset 11Oct2024 at 07:00, outcome "not recovered", described as "mild chills". Therapeutic measures were not taken as a result of pain, headache, chills, vaccination site pain, fatigue.  Additional information: The patient did not receive any other vaccines on the same date as the vaccine. The patient was taking other medications within 2 weeks of the event starting.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300334791 Same patient, different dose/event  (Dose 5);US-PFIZER INC-202201370111 Same patient, different dose/event (Dose 4);US-PFIZER INC-202101837776 Same patient, different dose/event (Dose 3);US-PFIZER INC-2021209379 Same patient, different dose/event (Dose 2);US-PFIZER INC-2021116255 Same patient, different dose/event (Dose 1);